Related Experiment Video
Updated: Feb 24, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
9.6K
Radical prostatectomy in oligometastatic prostate cancer
Philipp Mandel1, Thomas Steuber, Markus Graefen
1Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Current Opinion in Urology
|August 22, 2017
Summary
Radical prostatectomy (RP) may reduce severe local complications in oligometastatic prostate cancer. However, oncological benefits require further study, and patients should consider risks and enroll in clinical trials.
Area of Science:
- Urology
- Oncology
- Surgical Oncology
Background:
- Cytoreductive surgery improves survival in metastatic cancers.
- The role of surgery in oligometastatic prostate cancer remains uncertain.
Purpose of the Study:
- To evaluate the feasibility and outcomes of radical prostatectomy (RP) in patients with oligometastatic prostate cancer.
- To compare RP outcomes with systemic therapy for this patient group.
Main Methods:
- Review of literature on radical prostatectomy for oligometastatic prostate cancer.
- Analysis of perioperative complications, functional outcomes, and oncological benefits.
Main Results:
- RP is feasible in oligometastatic prostate cancer, with complication rates (20-50%) comparable to locally advanced tumors.
- Postoperative functional outcomes (urinary continence, erectile function) may be slightly worse than in locally advanced cases.
- RP significantly reduces severe local complications compared to systemic therapy (less than 10% vs. over 50%).
Conclusions:
- RP can significantly lower local complications in oligometastatic prostate cancer.
- Counsel patients on potential functional trade-offs and the current lack of prospective oncological data.
- Enrollment in prospective, randomized trials is recommended for patients considering RP.
